Take­da shift­ing hun­dreds of R&D staffers to Boston — re­port; Shire inks he­mo­phil­ia deal; Am­gen, Ar­ray part­ner on au­toim­mune dis­eases

Mod­ern Health­care re­ports that Take­da has been re­lo­cat­ing hun­dreds of R&D jobs out of Chica­go and in­to its big new biotech hub in Boston/Cam­bridge. Ac­cord­ing to the re­port, Take­da has re­quired up to 600 R&D staffers in Chica­go to re­lo­cate, along with 150 in the vac­cines group. Take­da has been shred­ding its old glob­al R&D struc­ture to fa­vor a con­cen­tra­tion of forces in Boston and Japan. But the com­pa­ny, un­der CEO Christophe We­ber and R&D chief Andy Plump, have main­tained a con­sid­er­able air of se­cre­cy in how they’re up­root­ing groups in an ef­fort to re­or­ga­nize and cre­ate a far more ef­fec­tive bio­phar­ma com­pa­ny.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.